Oncology Pharma (ONPH) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Oncology Pharma Short Interest DataOncology Pharma (ONPH) has a short interest of 13,500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 4.1, indicating that it would take 4.1 days of the average trading volume of 7,282 shares to cover all short positions.Current Short Interest13,500 sharesPrevious Short Interest13,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio4.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares38,663,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume3,395 sharesAverage Trading Volume7,282 sharesToday's Volume Vs. Average47% Short Selling Oncology Pharma? Sign up to receive the latest short interest report for Oncology Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartONPH Short Interest Over TimeONPH Days to Cover Over TimeONPH Percentage of Float Shorted Over Time Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Oncology Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202413,500 shares $0.00 No ChangeN/A4.1 $0.00 10/15/202413,500 shares $1.35 No ChangeN/A3.8 $0.00 9/30/202413,500 shares $0.00 No ChangeN/A1.1 $0.00 9/15/202413,500 shares $0.00 No ChangeN/A0.4 $0.00 8/31/202413,500 shares $0.00 No ChangeN/A0.5 $0.00 8/15/202413,500 shares $2.70 No ChangeN/A4.7 $0.00 Get the Latest News and Ratings for ONPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/202413,500 shares $2.70 No ChangeN/A9.6 $0.00 7/15/202413,500 shares $0.00 No ChangeN/A1.2 $0.00 6/30/202413,500 shares $0.00 No ChangeN/A4.8 $0.00 6/15/202413,500 shares $0.00 No ChangeN/A4.8 $0.00 5/31/202413,500 shares $0.00 -3.6%N/A2.7 $0.00 5/15/202414,000 shares $0.00 +3.7%N/A6.1 $0.00 4/30/202413,500 shares $0.00 No ChangeN/A1.5 $0.00 4/15/202413,500 shares $135.00 No ChangeN/A1.2 $0.01 3/31/202413,500 shares $1.35 No ChangeN/A4.5 $0.00 3/15/202413,500 shares $0.00 -0.7%N/A1.7 $0.00 2/29/202413,600 shares $0.00 No ChangeN/A2.4 $0.00 2/15/202413,600 shares $0.00 No ChangeN/A2.7 $0.00 1/15/202413,600 shares $0.00 No ChangeN/A3 $0.00 12/31/202313,600 shares $2.72 -4.9%N/A0.1 $0.00 12/15/202314,300 shares $2.86 -10.1%N/A0.3 $0.00 11/30/202315,900 shares $15.90 -52.0%N/A1 $0.00 11/15/202333,100 shares $33.10 -32.2%N/A2.7 $0.00 10/31/202348,800 shares $976.00 -17.2%N/A10 $0.02 10/15/202358,900 shares $2,208.75 -35.5%N/A6.5 $0.04 9/30/202391,300 shares $5,934.50 -1.0%N/A13.8 $0.07 9/15/202392,200 shares $4,378.58 -1.4%N/A10.5 $0.05 8/31/202393,500 shares $2,337.50 +523.3%N/A4.3 $0.03 8/15/202315,000 shares $4,275.00 -6.8%N/A0.2 $0.29 7/31/202316,100 shares $5,726.77 +16.7%N/A0.3 $0.36 7/15/202313,800 shares $5,422.02 -21.1%N/A0.3 $0.39 6/30/202317,500 shares $5,600.00 +19.9%N/A0.1 $0.32 6/15/202314,600 shares $8,176.00 -3.3%N/A0 $0.56 5/31/202315,100 shares $2,114.00 -22.6%N/A0.1 $0.14 5/15/202319,500 shares $2,730.00 +20.4%N/A0.1 $0.14 4/30/202316,200 shares $2,592.00 -30.5%N/A0.1 $0.16 4/15/202323,300 shares $3,902.75 -14.7%N/A0.2 $0.17 3/31/202327,300 shares $5,050.50 +45.2%N/A0.1 $0.19 3/15/202318,800 shares $5,452.00 -25.1%N/A0.2 $0.29 2/28/202325,100 shares $9,086.20 +9.6%N/A0.4 $0.36We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 2/15/202322,900 shares $8,702.00 -24.7%N/A0.2 $0.38 1/31/202330,400 shares $11,704.00 +28.8%N/A0.3 $0.39 1/15/202323,600 shares $9,676.00 -32.2%N/A0.1 $0.41 12/30/202234,800 shares $11,781.89 +5.1%N/A0.1 $0.34 12/15/202233,100 shares $16,881.00 -3.2%N/A0.2 $0.51 11/30/202234,200 shares $24,538.50 -6.8%N/A0.6 $0.72 11/15/202236,700 shares $34,131.00 -35.8%N/A0.2 $0.93 10/31/202257,200 shares $50,845.08 -5.9%N/A0.5 $0.89 10/15/202260,800 shares $26,144.00 -60.2%N/A0.4 $0.43 9/30/2022152,700 shares $70,242.00 +2.9%N/A1 $0.46 9/15/2022148,400 shares $129,093.16 +1.0%N/A2.5 $0.87 8/31/2022146,900 shares $149,838.00 -0.2%N/A1.6 $1.02 8/15/2022147,200 shares $198,720.00 -14.6%N/A1.3 $1.35 7/31/2022172,400 shares $231,016.00 -6.7%N/A1.1 $1.34 7/15/2022184,700 shares $265,968.00 -33.3%N/A1.2 $1.44 6/30/2022276,800 shares $405,788.80 -4.2%N/A3.7 $1.47 6/15/2022288,900 shares $433,350.00 -28.2%N/A1.8 $1.50 5/31/2022402,600 shares $805,200.00 -3.3%N/A4.3 $2.00 5/15/2022416,300 shares $865,279.55 -3.8%N/A2.8 $2.08 4/30/2022432,500 shares $1.28 million -1.0%N/A4.2 $2.96 4/15/2022437,000 shares $1.56 million +1.8%N/A4.2 $3.57 3/31/2022429,400 shares $1.59 million -16.6%N/A3 $3.70 3/15/2022515,000 shares $2.11 million -4.8%N/A1.6 $4.10 2/28/2022541,000 shares $2.75 million -4.0%N/A1 $5.08 2/15/2022563,400 shares $3.61 million +41.1%N/A1.2 $6.41 1/31/2022399,400 shares $1.34 million +4.0%N/A3.4 $3.36 1/15/2022384,100 shares $1.43 million -9.3%N/A1.4 $3.72 12/31/2021423,300 shares $1.71 million +5.4%N/A0.8 $4.05 12/15/2021401,700 shares $1.27 million +25.2%N/A0.8 $3.15 11/30/2021320,800 shares $1.75 million +4.8%N/A0.9 $5.44 11/15/2021306,200 shares $2.50 million -18.1%N/A0.4 $8.15 10/29/2021373,800 shares $4.68 million -9.8%N/A0.4 $12.52 10/15/2021414,600 shares $5.78 million +37.7%N/A0.5 $13.95 9/30/2021301,200 shares $3.26 million +78.0%N/A0.7 $10.82 9/15/2021169,200 shares $2.29 million +3.2%N/A0.4 $13.53 8/31/2021164,000 shares $3.15 million +98.6%N/A0.4 $19.20 8/13/202182,600 shares $1.68 million +32.2%N/A0.2 $20.30 7/30/202162,500 shares $1.39 million +79.1%N/A0.1 $22.17 7/15/202134,900 shares $731,155.00 +160.5%N/A0.1 $20.95 6/30/202113,400 shares $0.00 -82.2%N/A0 $0.00 ONPH Short Interest - Frequently Asked Questions What is Oncology Pharma's current short interest? Short interest is the volume of Oncology Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 13,500 shares of ONPH short. Learn More on Oncology Pharma's current short interest. What is a good short interest ratio for Oncology Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONPH shares currently have a short interest ratio of 4.0. Learn More on Oncology Pharma's short interest ratio. How does Oncology Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "computer software" compare to Oncology Pharma: Grom Social Enterprises, Inc. (1.03%), Infinite Group, Inc. (0.12%), AGM Group Holdings Inc. (0.22%), Baijiayun Group Ltd (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Pharma stock? Short selling ONPH is an investing strategy that aims to generate trading profit from Oncology Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Pharma? A short squeeze for Oncology Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ONPH, which in turn drives the price of the stock up even further. How often is Oncology Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONPH, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Grom Social Enterprises Short Squeeze Infinite Group Short Squeeze AGM Group Short Squeeze American Green Short Squeeze AppTech Payments Short Squeeze Arbe Robotics Short Squeeze Arogo Capital Acquisition Short Squeeze Artificial Intelligence Technology Solutions Short Squeeze Aurora Innovation Short Squeeze AvePoint Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ONPH) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncology Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
